You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment-naive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))

Active, not recruiting
  • Prostate Cancer
  • Multiparametric magnetic resonance imaging (mpMRI)
  • Taoyuan, Taiwan
    Li-Jen Wang
Nov 9, 2023

GHD Trial in Fort Worth (GenSci004, Genotropin)

Not yet recruiting
  • GHD
  • Fort Worth, Texas
    Cook Childrens
Aug 24, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib, Polatuzumab Vedotin, Rituximab
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 10, 2023

Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • (no location specified)
Aug 4, 2023

Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Pembrolizumab, Etoposide, Cisplatin or Carboplatin
  • Milano, Italy
  • +2 more
Oct 10, 2023

Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

Recruiting
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))

Not yet recruiting
  • HIV-1-infection
  • Low-dose STP0404 (Pirmitegravir)
  • +3 more
  • (no location specified)
May 16, 2023

The First Affiliated Hospital of Nanchang University Trial in Nanchang, Jinan (Orelabrutinib+R-CHOP)

Recruiting
  • The First Affiliated Hospital of Nanchang University
  • Nanchang, Jiangxi, China
  • +1 more
Jul 3, 2023

Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)

Active, not recruiting
  • Hiv
  • HIV-1-infection
  • Lamivudine 300 MG
  • Emtricitabine / Tenofovir Disoproxil Pill
  • Buenos Aires, Argentina
    Fundacion IDEAA
Jan 2, 2023

Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)

Completed
Has Results
  • Helicobacter Pylori Infection
  • New York, New York
    Mount Sinai Union Square Division of Digestive Diseases
Jan 6, 2023

Chronic Hepatitis b Trial in Chongqing, Xi'an (Placebo, TQA3605 tablets, Entecavir dispersible tablets)

Recruiting
  • Chronic Hepatitis b
  • Placebo
  • +4 more
  • Chongqing, Chongqing, China
  • +2 more
Nov 27, 2023

Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept

Not yet recruiting
  • Diabetic Macular Edema
  • +2 more
  • Vitrectomy combined with ILM peeling
  • Conbercept intravitreal injection
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Feb 14, 2023

HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to DOR/ISL)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Jan 20, 2023

Severe Aplastic Anemia Trial in Tianjin (Hetrombopag Olamine+Standard Therapy, Placebo+Standard Therapy)

Recruiting
  • Severe Aplastic Anemia
  • Hetrombopag Olamine+Standard Therapy
  • Placebo+Standard Therapy
  • Tianjin, Tianjin, China
    Blood Diseases Hospital, Chinese Academy of Medical Sciences
Jul 28, 2022

Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)

Completed
  • Chronic Hepatitis B
  • NCO-48 Fumarate 4 mg
  • +2 more
  • Monterey Park, California
    National Institute of Clinical Research, Inc
Jan 3, 2023

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Liposarcoma, Dedifferentiated Trial (Brigimadlin)

Not yet recruiting
  • Liposarcoma, Dedifferentiated
  • (no location specified)
Sep 22, 2023

NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +8 more
  • New Haven, Connecticut
    Yale University
Oct 26, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

HIV Trial in Worldwide (VH3739937, Placebo)

Not yet recruiting
  • HIV Infections
  • Bakersfield, California
  • +18 more
Sep 22, 2023

Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • (no location specified)
Jul 10, 2023

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

Recruiting
  • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
  • Olverembatinib plus venetoclax and dexamethasone
  • Xi'an, Shannxi, China
    Department of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Shanghai (Orelabrutinib + R-CHOP, Placebo + R-CHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Orelabrutinib + R-CHOP
  • Placebo + R-CHOP
  • Shanghai, Shanghai, China
    Shanghai Ruijing Hospital
Nov 28, 2022